183 related articles for article (PubMed ID: 27034170)
1. Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells.
Chen Y; Cang S; Han L; Liu C; Yang P; Solangi Z; Lu Q; Liu D; Chiao JW
Oncotarget; 2016 May; 7(18):26567-79. PubMed ID: 27034170
[TBL] [Abstract][Full Text] [Related]
2. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
Wang LG; Liu XM; Chiao JW
Carcinogenesis; 2006 Oct; 27(10):2124-32. PubMed ID: 16704988
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
4. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review).
Wang LG; Chiao JW
Int J Oncol; 2010 Sep; 37(3):533-9. PubMed ID: 20664922
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.
Singh KB; Hahm ER; Rigatti LH; Normolle DP; Yuan JM; Singh SV
Cancer Prev Res (Phila); 2018 Jun; 11(6):337-346. PubMed ID: 29545400
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
8. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate.
Chiao JW; Chung F; Krzeminski J; Amin S; Arshad R; Ahmed T; Conaway CC
Int J Oncol; 2000 Jun; 16(6):1215-9. PubMed ID: 10811998
[TBL] [Abstract][Full Text] [Related]
9. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
10. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.
Yu C; Gong AY; Chen D; Solelo Leon D; Young CY; Chen XM
Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605
[TBL] [Abstract][Full Text] [Related]
11. Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1.
Zhang T; Zhang W; Hao M
Oncol Rep; 2021 Jan; 45(1):337-348. PubMed ID: 33416137
[TBL] [Abstract][Full Text] [Related]
12. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
13. Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation.
Wu J; Cang S; Liu C; Ochiai W; Chiao JW
Exp Hematol Oncol; 2020; 9():12. PubMed ID: 32537260
[TBL] [Abstract][Full Text] [Related]
14. DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice.
Wu R; Li S; Sargsyan D; Yin R; Kuo HC; Peter R; Wang L; Hudlikar R; Liu X; Kong AN
Mol Carcinog; 2021 Jun; 60(6):391-402. PubMed ID: 33848375
[TBL] [Abstract][Full Text] [Related]
15. Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.
Fukami K; Sekiguchi F; Yasukawa M; Asano E; Kasamatsu R; Ueda M; Yoshida S; Kawabata A
Biochem Pharmacol; 2015 Oct; 97(3):300-9. PubMed ID: 26256074
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.
Hudson TS; Perkins SN; Hursting SD; Young HA; Kim YS; Wang TC; Wang TT
Int J Oncol; 2012 Apr; 40(4):1113-21. PubMed ID: 22266918
[TBL] [Abstract][Full Text] [Related]
17. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
18. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
Sabnis NG; Miller A; Titus MA; Huss WJ
Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
[TBL] [Abstract][Full Text] [Related]
19. Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells.
Wang D; Upadhyaya B; Liu Y; Knudsen D; Dey M
BMC Cancer; 2014 Aug; 14():591. PubMed ID: 25127663
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
